Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
January 6th, 2016
Google Books Litigation: Frankfurt Kurnit Petitions US Supreme Court for Review
IP litigation partners Ned Rosenthal and Jeremy Goldman are co-counsel for The Authors Guild in the so-called Google Books case — arguably the most significant copyright case in the courts today. The case advances a direct challenge to Google’s mass digitization of millions of copyrighted works for inclusion in its search engine and as part of its “library project.” The Second Circuit had ruled for Google. Working with our co-counsel at Jenner & Block LLP, we have asked the US Supreme Court to resolve the conflict over whether use of a copyrighted work that adds no new creative content can nevertheless be "transformative" for fair use purposes - and other questions at the heart of publishing in the digital age. You may read the cert petition here.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
